logo
International Conference and Exhibition on
Biowaivers and Biosimilars
September 10-12, 2012 Hilton San Antonio Airport, USA
 
Biosimilars-2012

    Previous Events
     
     
    Participants List from Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    Universidade Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    Universidade de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

     
    Participants List from Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women's Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy's labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    International Conference and Exhibition on Biowaivers and Biosimilars will be organized around the theme "A Synergistic Approach towards Biowaivers & Biosimilars".

    Biosimilars-2012 is comprised of 10 tracks and 58 sessions designed to offer comprehensive sessions that address current issues in Biowaivers and Biosimilars.

    Submit your abstract to any of the following tracks. All related abstracts are accepted.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Track 1: Biosimilars: Innovator Pharmaceutical Products
    Track 1-1 Biosimilars: An overview
    Track 1-2 Biotechnology medicinal products different from drugs
    Track 1-3 Future of next generation biosimilars
    Track 1-4 Challenges faced in developing biosimilars
    Track 2: Biosimilars: Regulatory Approach
    Track 2-1 Licensing of biosimilars
    Track 2-2 Biosimilars regulation
    Track 2-3 Patent filling
    Track 2-4 FDA's view on biosimilars
    Track 3: Skill Set for Biosimilars Development
    Track 3-1 Immunogenicity
    Track 3-2 Project management and laboratory management
    Track 3-3 Clinical development
    Track 3-4 Pharmacovigilance
    Track 3-5 Biosimilars development
    Track 3-6 Biomedical informatics
    Track 3-7 Nanobiotechnology
    Track 4: Clinical Studies
    Track 4-1 Clinical trials
    Track 4-2 Risk management and quality affairs
    Track 4-3 Transgenic animals
    Track 4-4 Targeted cell line development
    Track 4-5 Clinical PK/PD studies
    Track 4-6 Toxicology
    Track 4-7 Aspects of genotoxicity tests
    Track 5: Biosimilars Therapeutics
    Track 5-1 Recombinant blood products
    Track 5-2 Recombinant vaccines
    Track 5-3 Growth hormones
    Track 5-4 Biosimilar peptides
    Track 5-5 Recombinant therapeutic proteins
    Track 5-6 Biosimilars in cancer treatment
    Track 5-7 Biosimilars monoclonal antibodies
    Track 5-8 Biosimilar interferon
    Track 6: Commercialization or Globalization of Biosimilars
    Track 6-1 Biosimilar drugs
    Track 6-2 Economic aspect towards biosimilars
    Track 6-3 Biosimilars in market
    Track 6-4 Investment and returns on biosimilars
    Track 7: Plant Produced Biosimilar Products
    Track 7-1 Transgenic plants
    Track 7-2 Post translational genetics
    Track 7-3 Fermentation culture
    Track 7-4 Molecular farming
    Track 8: Aggregation and Immunogenicity of Biosimilars
    Track 8-1 Auto-Oxidation of polysorbate surfactants and protein damage
    Track 8-2 Aggregation and immunogenicity
    Track 8-3 Aggregation and product loss during manufacture
    Track 8-4 Development of neutralizing antibodies and loss of efficacy
    Track 9: BCS & IVIVC Based Biowaivers
    Track 9-1 BCS Biowaivers: An overview
    Track 9-2 Preclinical and clinical testing for oral drug delivery
    Track 9-3 Waiver for In vivo bioavailability or bioequivalence
    Track 9-4 Consideration of biowaiver extensions for BCS class III drugs
    Track 9-5 IVIVC based biowaivers
    Track 9-6 In vitro diffusion cells for dissolution testing in formulation development
    Track 9-7 Dissolution testing in drug formulation
    Track 9-8 In vitro preclinical ADME/BCS testing
    Track 9-9 In vitro drug product research
    Track 10: Analytical Strategies
    Track 10-1 Bioanalytical methods
    Track 10-2 Formulation
    Track 10-3 Bioassay for comparability & potency testing
    Track 10-4 GMP protein analysis
    Track 10-5 LC/MS analysis for discovery, preclinical and clinical programs
    Track 10-6 Electrophoresis
    Track 10-7 Multimodal techniques
     
    follow
    Conference Secretariat: Biosimilars-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Tel: +1-650-268-9744 | Fax: +1-650-618-1414
    Toll free: 1-800-216-6499 (USA & Canada), 1-800-651-097 (Australia), 0805-080048 (Europe)
    Email: biosimilars2012@omicsgroup.com
    Operated by: Editors- Journal of Bioanalysis and Biomedicine, Journal of Bioequivalence and Bioavailability, Pharmaceutica Analytica Acta
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version